We just received data on a new analyst forecast for $COHR. Barclays gave a rating of 'Overweight' for $COHR.
$COHR Analyst Ratings
Wall Street analysts have issued reports on $COHR in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 10/20/2025
- Needham issued a "Buy" rating on 08/14/2025
- Stifel issued a "Buy" rating on 08/14/2025
- Rosenblatt issued a "Buy" rating on 08/14/2025
- Susquehanna issued a "Positive" rating on 07/22/2025
- JP Morgan issued a "Overweight" rating on 07/17/2025
- Wolfe Research issued a "Outperform" rating on 07/08/2025
To track analyst ratings and price targets for $COHR, check out Quiver Quantitative's $COHR forecast page.
$COHR Price Targets
Multiple analysts have issued price targets for $COHR recently. We have seen 11 analysts offer price targets for $COHR in the last 6 months, with a median target of $120.0.
Here are some recent targets:
- Tom O'Malley from Barclays set a target price of $135.0 on 10/20/2025
- Mike Genovese from Rosenblatt set a target price of $150.0 on 10/14/2025
- Meta Marshall from Morgan Stanley set a target price of $120.0 on 10/10/2025
- Vivek Arya from B of A Securities set a target price of $105.0 on 08/14/2025
- Ryan Koontz from Needham set a target price of $120.0 on 08/14/2025
- Ruben Roy from Stifel set a target price of $118.0 on 08/14/2025
- Mehdi Hosseini from Susquehanna set a target price of $120.0 on 07/22/2025
$COHR Congressional Stock Trading
Members of Congress have traded $COHR stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $COHR stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$COHR Insider Trading Activity
$COHR insiders have traded $COHR stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $COHR stock by insiders over the last 6 months:
- SHAKER SADASIVAM sold 29,292 shares for an estimated $2,343,360
- CHRISTOPHER KOEPPEN (EVP of Aerospace & Defense) has made 0 purchases and 8 sales selling 19,838 shares for an estimated $1,738,835.
- JULIE SHERIDAN ENG (EVP, Engineering) has made 0 purchases and 4 sales selling 7,136 shares for an estimated $647,050.
- HOWARD H. XIA has made 0 purchases and 6 sales selling 6,000 shares for an estimated $472,405.
- STEPHEN A SKAGGS sold 2,000 shares for an estimated $244,460
- LISA NEAL-GRAVES sold 1,200 shares for an estimated $95,577
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$COHR Hedge Fund Activity
We have seen 398 institutional investors add shares of $COHR stock to their portfolio, and 235 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DODGE & COX removed 4,706,174 shares (-73.1%) from their portfolio in Q2 2025, for an estimated $419,837,782
- BLACKROCK, INC. removed 2,532,860 shares (-13.3%) from their portfolio in Q2 2025, for an estimated $225,956,440
- INVESCO LTD. removed 2,056,449 shares (-25.2%) from their portfolio in Q2 2025, for an estimated $183,455,815
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 1,569,406 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $140,006,709
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. added 1,402,116 shares (+333.4%) to their portfolio in Q2 2025, for an estimated $125,082,768
- AMERIPRISE FINANCIAL INC added 1,389,126 shares (+147.3%) to their portfolio in Q2 2025, for an estimated $123,923,930
- CITADEL ADVISORS LLC added 1,279,310 shares (+1044.1%) to their portfolio in Q2 2025, for an estimated $114,127,245
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
